ResearcherChina Pharmaceutical UniversityNo recent work listed

Yuepeng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-4003-0680; OpenAlex author ID A5075600415. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.ejmech.2023.115846 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yungen Xu · 1 shared paper, 2023 · strength 0.17
- Paper Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pa… DOI 10.1016/j.ejmech.2023.115846 ↗
Wenze Wang · 1 shared paper, 2023 · strength 0.17
- Paper Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pa… DOI 10.1016/j.ejmech.2023.115846 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.